4AB:FRA
AbbVie Common Stock
233,10 €
arrow_upward
+1,30%(+3,00) 1D
2-окт., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 миң
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 миң
News stories
From web sources and news partners
AD HOC NEWS
·
7 саат мурун
AbbVie stock gained 1.11 percent before October 30 results
Insider Monkey
·
12 саат мурун
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
Yahoo Finance
·
1 күн мурун
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
MarketWatch
·
1 күн мурун
AbbVie Inc. stock outperforms competitors on strong trading day
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com